BV FINANCIAL, INC. ANNOUNCES FINANCIAL RESULTS

BV Financial, Inc. (BVFL) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Contact: Michael J. Dee Chief Financial Officer (410) 477- 5000 BV FINANCIAL, INC. ANNOUNCES FINANCIAL RESULTS Baltimore, Maryland, October 23, 2026– BV Financial, Inc. (NASDAQ: BVFL), the holding company for BayVanguard Bank (the “Bank”), today reported net income o

Event · Earnings
Also in this documentBuyback · 163.54K

Facts are quoted from the filing text and checked against it.

Original reporting
Published Oct 23, 2026, 1:26 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 23, 2026, 1:26 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$BVFL
Bearish
medium confidence
Mentioned
$BVFL
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$BVFLBearishLow
01

Why it matters

The earnings release provides the first public disclosure of the quarter's financials, offering fresh data for traders.

02

Market read

Small‑cap banking earnings with modest miss; limited but actionable for niche investors.

03

What to watch

Improved net interest margin and lower credit loss provisions may offset loan decline.

Relevance 7/10Novelty 7/10Timing: same day release

Background

BV Financial is a holding company for BayVanguard Bank, reporting quarterly results on its SEC Form 8‑K.

Company-level read

Ticker impact

$BVFLBearishMedium confidence
Context

BV Financial reported Q3 2026 earnings via an 8‑K, showing net income of $3.4 M versus $3.7 M a year ago and a decline in loan portfolio.

Expected impact

likely slight decline as investors price in lower income and loan growth

Evidence & confidence

Revenue and net income fell year‑over‑year; loan balances dropped 2.9%, indicating weaker core earnings.

Market effects

Regional bank sector may see modest pressure from BVFL's loan contraction.

Limited to U.S. small‑cap banking niche.

Low; no broader macro effect.

Counterpoint

The share buyback of 163,540 shares at $21.16 could support price despite earnings dip.

Key entities

  • BV Financial, Inc.

    NASDAQ‑listed regional bank holding company.

  • Federal Home Loan Bank of Atlanta

    Source of borrowings that were repaid during the quarter.

Related articles

$BVFLMed

BV FINANCIAL, INC. ANNOUNCES FINANCIAL RESULTS

BV Financial, Inc. (BVFL) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 bvfl-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 Contact: Michael J. Dee Chief Financial Officer (410) 477- 5000 BV FINANCIAL, INC. ANNOUNCES FINANCIAL RESULTS Baltimore, Maryland, July 24, 2026– BV Financial, Inc. (NASDAQ: BVFL), the holding company for BayVanguard Bank (t

$NMAXMed

Why Newsmax Stock Popped on Friday

Newsmax (NMAX) shares rose 31% after reporting Q3 revenue of $69M, up 52.5% YoY, and net income of $15.2M. The company cited strong audience engagement and growth in high-margin revenue streams. CEO Christopher Ruddy expects continued growth ahead of the presidential election.

$LUNRMed

What Is Driving Intuitive Machines Stock?

Intuitive Machines (LUNR) shares rose 7.0% on Nov 12, 2026, after reporting Q3 revenue of $269M, beating estimates. The company's loss of $0.10 per share met expectations, while gross margin improved to 26%. Free cash flow turned positive at $33M, a company record. Management raised full-year revenue guidance to $920M-$950M. The stock's performance contrasted with broader industry declines.

$RMIXMedAI 8/10

Suncrete (RMIX) Q3 2026 Earnings Call Transcript

Suncrete (RMIX) reported Q3 2026 revenue of $141M, up 45% QoQ and 163% YoY. Adjusted EBITDA rose 66% QoQ to $22.4M. The company lowered its full-year outlook due to residential construction weakness but remains confident in long-term demand. Acquisition integration is progressing, with North Texas showing margin improvement. Suncrete expects $200M-$250M revenue from 2026 acquisitions in 2027. The company has $206.5M in total liquidity.

$CLLSMed

Cellectis SA (CLLS) (Q3 2026) Earnings Call Highlights: Strategic Shift to Gene

Cellectis SA (CLLS) discussed its strategic shift to gene editing during its Q3 2026 earnings call. Management highlighted the selection of APOC3 over ANGPTL3 for triglyceride reduction, with plans to start Phase 1 dosing by end-2027. The company reported $149M in cash as of September 30, 2026, with a runway into H2 2028. Revenue decreased to $19.9M from $67.4M YoY, while R&D expenses increased to $108.8M from $69.1M, driven by the AstraZeneca collaboration.